TABLE 3.
Mating IDb | Strain ID | Resistance phenotype | AmpC gene | Plasmid(s) identified | IncK2 contig size (bp) |
---|---|---|---|---|---|
Solid plate | |||||
SH-2813don | SH-13A-48h-NalAmpphe | Amp, Amc, Fox, Cro, Nal | CMY-2 | IncX1, IncK2 | 88,798 (C) |
SH-2813recc | SH-14A-48h-NalAmpphe | Str, Nal | None | IncX1 | NA |
SH-2813don | SH-13A-48h-NalAmpphe | Amp, Amc, Fox, Cro, Nal | CMY-2 | IncX1, IncK2 | 88,798 (C) |
Ec15cecarec | Ec15ceca | Tet | None | IncFIB, Col440i | NA |
SH2813_D_Ec15ceca_R | NA | Amp, Amc, Fox, Cro, Tet | CMY-2 | IncK2, IncFIB, Col440i | 88,178 |
SH2813_D_Ec15ceca_Rdon | NA | Amp, Amc, Fox, Cro, Tet | CMY-2 | IncK2, IncFIB, Col440i | 88,178 |
SH-2813rec | SH-2813-Parentaltyr | Nal | None | IncX1 | NA |
Ec15ceca_D_SH2813_R | NA | Amp, Amc, Fox, Cro, Nal | ND | ND | ND |
Ec6BLdon | Ec6BL | Amp, Amc, Fox, Cro, Gen, Str, Smx, Tet | CMY-2 | IncK2, IncF4:A5:B1, IncFII, Col (MG828) | 88,889 (C)e |
SH-2813rec | SH-2813-Parentaltyr | Nal | None | IncX1 | NA |
Ec6BL_D_SH2813_R2 | NA | Gen, Str, Smx, Tet, Nal | None | IncFII, IncX1 | NA |
Ec6BL_D_SH2813_R | NA | Amp, Amc, Fox, Cro, Nal | CMY-2 | IncK2, IncX1 | 85,244 |
Ec15BLdon | Ec15BL | Amp, Amc, Fox, Cro | CMY-2 | IncK2, IncF4:A-:B1, Col (MG828) | 85,509e |
SH-2813rec | SH-2813-Parentaltyr | Nal | None | IncX1 | NA |
Ec15BL_D_SH2813_Rd | NA | Amp, Amc, Fox, Cro, Nal | CMY-2 | IncK2, IncX1 | 84,268, 84,274, 84,273 |
Broth | |||||
SH-2813don | SH-13A-48h-NalAmpphe | Amp, Amc, Fox, Cro Nal | CMY-2 | IncX1, IncK2 | 88,798 (C) |
SH-2813recc | SH-2813 | None | None | IncX1 | NA |
Abbreviations: ID, identifier; Gen, gentamicin; don, donor; rec, recipient; ND, not determined; NA, not applicable; C, complete circular contigs.
Boldface indicates recombinant strains with acquired antibiotic resistance.
Recipient did not acquire β-lactamase resistance from donor.
WGS was done on 3 individual colonies that acquired β-lactamase resistance from the donor.
De novo hybrid assembly was done using Illumina short- and MinION long-read technology (see also Table S5).